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Abstract
Background: Co-occurrence of mental and somatic symptoms is common, and recent longitudinal studies have
identified single trajectories of these symptoms, but it is poorly known whether the symptom trajectories can also
co-occur and change across the lifespan. We aimed to examine co-occurring symptoms and their joint trajectories
from adolescence to midlife.
Methods: Longitudinal data were derived from Northern Sweden, where 506 girls and 577 boys aged 16 years
participated at baseline in 1981 (99.7% of those initially invited), and have been followed up in four waves until the
age of 43. Survey data were collected about depressive, anxiety, and somatic symptoms. Potential joint development
of this three-component symptom set was examined with multiple response trajectory analysis, a method that has not
been previously used to study co-occurrence of these symptoms.
Results: We identified a five trajectory solution as the best: “very low” (19%), “low” (31%), “high” (22%), “late sharply
increasing” (16%) and a “very high increasing” (12%). In the “late sharply increasing” and “very high increasing” groups
the scores tended to increase with age, while in the other groups the levels were more stable. Overall, the results
indicated that depressive, anxiety, and somatic symptoms co-exist from adolescence to midlife.
Conclusions: The multiple response trajectory analysis confirmed high stability in the co-occurrence of depressive,
anxiety, and somatic symptoms from adolescence to midlife. Clinicians should consider these findings to detect
symptoms in their earliest phase in order to prevent the development of co-occurring high levels of symptoms.
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Introduction
Mental disorders, such as depression and anxiety, are a not-
able global health challenge and major contributors to the
overall burden of disease, disability-adjusted life years, and
suicide [1, 2]. Moreover, depressive and anxiety symptoms
tend to co-exist with somatic symptoms. However, research
on the co-occurrence and co-development of the symp-
toms is sparse, while the majority of studies focus only on
depression [3]. To arrive at a more in-depth understanding
of the joint co-occurrence of mental and somatic symptoms
over time, studies focusing on trajectories of these different
symptoms over the lifespan are needed.
The importance of further investigation of co-occurrence
of symptoms was emphasized by the Zurich cohort study
[4], which showed that stable comorbid states are more
common than individual non-comorbid states. In other
words, there is a clear comorbidity of anxiety or depression,
which is stable from youth to adulthood. The strength of
the relationships warrants further research to focus on the
co-occurrence in particular, extending prior evidence about
single disorders. Also, a review concludes that there are
strong associations between depression, anxiety, and
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somatic symptoms, and suggests a reconsideration of exist-
ing nosology and re-conceptualization of symptomatic rela-
tionships [5]. However, studies have relatively short follow-
ups, and do not cover the lifespan from adolescence to
midlife. The review further emphasized the need for popu-
lation-based longitudinal studies focusing on the co-occur-
rence of depressive, anxiety, and somatic symptoms.
Among longitudinal studies examining individual
symptoms, a myriad of studies have focused on depres-
sion or depressive symptoms under various conditions
[6–14], whereas corresponding studies on anxiety [15–
18], and in particular on somatic symptoms [19], are
scarce. A couple of studies have investigated comorbid
depressiveness-anxiousness [4, 20–23]. Overall, however,
the focus areas or coverages of those previous studies
are limited to either early adolescence, early childhood,
older ages, or to one gender only, and the interest has
been in finding possible correlations with various predic-
tors rather than the co-occurrence of the symptoms and
their course across the lifespan. Previous studies have
further used different methods, e.g. log-linear models
[4], whereas multiple response trajectory analyses [24–
26] have not been previously used to examine the joint
occurrence of the internalized symptoms.
Therefore, studying the joint trajectories in these symp-
toms, covering a notable part of lifespan and the periods
when the symptoms often first occur, are warranted. If the
midlife mental and psychosomatic disorders have their
roots in earlier life, early detection of high-risk groups is
needed. Moreover, if the symptom trajectories are stable
over time, studies that aim to address and prevent these
symptoms have to more strongly tackle the symptoms
already in adolescence. A long follow-up from adoles-
cence to midlife, and identifying common and unique
joint trajectories in the symptoms, could help produce
new information for more timely intervention. More-
over, the results obtained with this methodological
approach could be taken into account when re-think-
ing diagnostic categories of mental health problems in
future [5].
Thus, to fill in these gaps in previous evidence, the
aim of this study was to apply multiple response trajec-
tory analyses in order to provide novel evidence about
the development and co-occurrence of depressive, anx-
iety, and somatic symptoms during the lifespan from
adolescence to midlife. More specifically, we examined
how far the three symptom types occur jointly, or
whether specific trajectories where there are one type of
symptoms only, could be identified. This is done by joint
group-based trajectory analysis (GBTA) [24–26], a novel
person-oriented method that enables identification of
development of the three symptoms types simultan-
eously. This kind of methodology has not been previ-
ously applied in the field of mental health.
Methods
Participants
Data for this analysis are derived from a longitudinal study,
which was set up in a medium-sized industrial city of Luleå
in Northern Sweden [27]. All students in their last year of
compulsory education in every school in that region partici-
pated at baseline in 1981 (506 girls and 577 boys). Practically
all of the originally invited students consented to participate
in the baseline investigation, i.e., 1080 out of 1083 boys and
girls (99.7%). Participants have been followed up in
altogether four waves: in 1981 (baseline age 16 years), 1986
(age 21 years), 1995 (age 30 years), and 2008 (age 43 years)
with an exceptionally high response rate over the follow-up
(more than 90% throughout the waves, Table 1). There was
also a follow-up at age 18, but mental health variables could
not be constructed at age 18, as the items in 1983 question-
naire were partly different. Otherwise, the format of the data
collection was kept similar at all time points.
The baseline survey at age 16 was completed in class-
rooms, while the follow-up surveys were collected in
classmate re-unions, by mail or by telephone using
trained professionals. Telephone interviews were made
mainly for those with reading and writing difficulties,
and some of the late responders. However, mainly, sur-
veys were based on self-rate paper format question-
naires. Two reminders were sent out. The response rates
were very high, so the reminders needed to only be sent
to a small number of those, who were not present when
the surveys were filled in. Thus, at age 16 almost every-
one filled in the questionnaire during school hours. At
the follow-ups after compulsory school, all cohort partic-
ipants were invited to class reunions. Those who could
not come received the questionnaire by post, followed
by reminders by post or by phone.
The interviewees were asked extensive sets of ques-
tions about their health. Additionally socio-economic
and clinical information was collected and measured
[28]. Final data used for this analysis thus comprised 1,
001 participants (482 women and 519 men).
The study was approved by the Regional Ethical Review
Board in Umeå, Sweden. Response to a survey was consid-
ered as consent to participate in the study. Moreover, in-
formation about the study was given orally to all pupils
before the study began. In addition, all pupils and their
parents received written information about the study in-
cluding that it was voluntary to participate. During all
years, it was stated in the questionnaire that participation
was voluntary and that they could leave the study at any
time without any explanation.
Measures
Mental health was measured following previous procedures
[27, 28]. However, to obtain more distinctive variables for
the trajectory analyses each item was included only in one
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of the scores. Moreover, ‘backache or sciatica’ was not in-
cluded in the somatic symptoms score as the conditions it
measures in midlife were considered to differ too much
from those in teenage [29].
Anxiety symptoms score comprised four items: 1. rest-
lessness, 2. concentration difficulties, 3. worry or anxiety,
and 4. anxiety or panic. Those who responded “No” to
all four symptoms scored 0. Another question asked
about frequency of the symptom(s). Those who
responded “Off and on” or “Never”, and had one or
more of the symptoms, scored 1, while those responding
“Often” or “All the time” scored 2. Total score was com-
puted as the mean of the four items, ranging continu-
ously from 0 to 2.
We included five symptoms for the depressive symp-
toms score: 1. sleeping problems (0–3), 2. poor appetite
(0–2), 3. general tiredness (0–2), 4. felt down and sad
(0–3), and 5. dejected about future (0–3). Items with re-
sponse range from 0 to 3 were recoded to 0–2 by com-
bining the intermediate responses. The score was
computed as the mean of the five included items.
Somatic symptoms score was based on six out of 43
symptoms: 1. headache or migraine, 2. nausea, 3. breath-
lessness, 4. dizziness, 5. overstrain, and 6. palpitations or
stomach problems. These symptoms were selected to
represent, according to an expert panel (64–96% agreed),
‘functional’ or ‘psychosomatic’ symptoms during adoles-
cence and early adulthood, and development of the
prevalence of these symptoms over time [29]. All items
scored from 0 to 2, and the total score was computed as
the mean of the six included individual item scores.
Statistical analysis
Individual changes in mental health symptoms over time
were investigated by a multivariate version of group-
based trajectory analysis (GBTA) [24–26]. The model
used here estimates joint developmental trajectories of
three distinct symptoms: depressive, anxiety, and som-
atic symptoms.
The mixture normal distribution was applied to de-
pressive and somatic symptoms, but the variable anxiety
was considered under mixture Poisson distribution. The
shape of the developmental progression curve for each
symptom was defined using statistical considerations.
Depressive symptoms score, for example, may not
develop linearly with age. Therefore, a linear shape
would be insufficient and hence a second degree polyno-
mial curve and the so-called broken stick model (knot
point age 21 [29]) was tested for each of the variables.
Note that a third degree polynomial model is not feas-
ible in our situation, since it yields to fully saturated
model (4 measurement points, 4 parameters to be esti-
mated). It turned out that for depressive and somatic
symptoms, the broken-stick model was better than the
second degree curve, but for anxiety symptoms, the sec-
ond degree model had a better fit. The modeling was
done in several steps using the statistical software R with
the package “flexmix” [30]. The determination of the
number of trajectory groups and their shapes (linear,
curvilinear, broken-stick) was based on visual inspection,
plots of posterior probabilities (rootograms) and Bayes-
ian Information Criterion (BIC) [30]. Men and women
were analyzed together, but additional sensitivity ana-
lyses were done stratified by gender due to possible
known differences in the level and incidence of the
symptoms between women and men [5].
The preferred number of groups is based on the use of
BIC information criterion. Here we tested the number of
groups k = 1,…,8. The BIC-values were: BIC(k = 1) =
15095.559; BIC(k = 2) = 10937.163; BIC(k = 3) = 10118.299;
BIC(k = 4) = 9811.781; BIC(k = 5) = 9541.862; BIC(k = 6) =
9411.699; BIC(k = 7) = 9329.122 and BIC(k = 8) = 9284.083.
It turned out that BIC values do not converge to the clear
minimum point, but the degrease in values for k = 6, 7 and
8 is only marginal (see also the plot in the Additional file 1:
Figure S1). Therefore, we used the solution of the five
groups k = 5, where neither group becomes too small to be
practical. Furthermore, the choice of five groups is also well
supported by reasonable practical interpretations and by
the U-shaped rootograms (see the Additional file 2: Figure
S2). Finally, missing data were very small, and were re-
moved at the modeling stage.
Results
Mental health and somatic symptoms of the entire co-
hort by wave (age at baseline and at each included fol-
low-up point) are described in Table 2. Anxiety and
somatic symptoms appeared to increase with age, while
depressive symptoms did not depend on age in any sys-
tematic manner. However, mean depressive symptoms
Table 1 Numbers of participants and their percentage of the original population at each study wave
Men (numbers) % of original Women (numbers) % of original
Original 577 506
16 years 574 99.5 506 100
21 years 560 97.1 500 98.8
30 years 551 95.5 495 97.8
43 years 523 90.6 487 96.2
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were higher at the beginning of the follow-up as com-
pared to the final follow-up point.
The groups identified by the joint trajectory analyses
are described in Fig. 1 by means of the scores in each
time point. The analysis discerned five distinctive
groups: “very low” (19%), “low” (31%), “high” (22%), “late
sharply increasing” (16%) and a “very high increasing”
(12%). In the first mentioned three groups, all three
scores tended to decrease by age, whereas in the “late
sharply increasing” and “very high increasing” groups all
curves sloped clearly upwards. Overall, the analysis indi-
cates that depressive, anxiety, and somatic symptoms
co-exist from adolescence to midlife in a stable manner,
or that the level at one point during the lifespan is
strongly associated with the past level, and also with the
future level of all types of symptoms.
Discussion
This is the first study to examine the joint co-occurrence
of depressive, anxiety and somatic symptoms over 27
years, covering the critical periods of transition e.g. first
from adolescence to adulthood, then education, transition
into paid employment, and working life span until midlife.
Joint trajectory analysis identified quite a consistent co-oc-
curring trajectory sets in this sample, reflecting 5 distinct
groups of very high and high levels of all three symptom
types, late sharply increasing, and more average-to-low
level trajectory sets.
Interpretation
Previous studies suggest that depressive, anxiety, and som-
atic symptoms are correlated [5]. However, to our know-
ledge, no previous study has combined the cross-sectional
Table 2 Means and standard deviations (SD) of depressive, anxiety and somatic symptoms at baseline (16 years) and at the follow-
up waves, and the total number of participants for men and women
Depressive symptoms Anxiety symptoms Somatic symptoms Total number of participants
Mean (SD) Mean (SD) Mean (SD)
16 years 0.54 (0.32) 0.13 (0.26) 0.28 (0.26) n = 996
21 years 0.45 (0.31) 0.16 (0.34) 0.24 (0.25) n = 996
30 years 0.50 (0.33) 0.22 (0.45) 0.35 (0.31) n = 981
43 years 0.49 (0.37) 0.23 (0.43) 0.37 (0.34) n = 996
Fig. 1 Multivariate trajectory plots of depressive, anxiety, and somatic symptoms scores in men and women from age 16 to age 43. [Late sharply
inc. (late sharply increasing), Very high inc. (very high increasing)]
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and longitudinal approaches as has been done in this
present study. By virtue of the multiple response trajectory
analysis, this study adds to previous knowledge about the
joint occurrence of the symptoms, highlighting the stabil-
ity of their co-occurrence also in the long run during the
lifespan.
More specifically, examining co-occurrence of different
symptoms from adolescence to midlife, this study sought
to identify what the similarities and differences are in the
development of these symptoms and their co-occurrence.
Furthermore, we focused on the different shapes and dif-
ferent directions in the curves. As our cohort is a random
population sample, the results can also be interpreted to
depict average development of the included symptoms by
age. It should be noted that a “normal” development and
course of these symptoms during the lifespan is not as-
sumed to be zero-level. However, the joint group-based
trajectory analyses break down the average into several
groups with different symptom levels. The size of these
groups helps us to understand the normal development.
The “very high increasing ” trajectory group appeared to
be characterized by increasing symptoms, in addition to
the high levels. The steepest increase was seen in anxiety
symptoms, the increase was evident in somatic symptoms,
and also visible in depressive symptoms. The high level of
the symptoms co-occurring during a long period in the
life span is a novel finding of this study. This clear co-oc-
currence should be considered in future studies and when
addressing any of these symptoms in any interventions or
health promotion/disease prevention programs. Moreover,
also practicing clinicians facing people with e.g. high levels
of depressive symptoms, might need to aim to identify the
presence and levels of the other symptoms as well. Fur-
thermore, these results suggest that clinicians should en-
deavor to detect symptoms in their earliest possible phase,
to prevent the development of co-occurring high levels of
depressive, anxiety, and somatic symptoms to continue, or
to increase over time. Thus, while the measured symp-
toms per se are not often clinically relevant, taken to-
gether the three measures could have clinical relevance,
suggesting that screening for symptoms might warrant re-
ferral to clinical care. Nonetheless, as this is an epidemio-
logical study, it needs to be acknowledged that it is not
possible to draw any direct conclusions or implications for
clinical practice. Successful prevention would, however,
have important public health and societal significance and
implications, as trajectories of mental disorders are associ-
ated with poor labor market outcomes such as unemploy-
ment and being neither in education, employment, nor
training [31, 32].
Additionally, when further interpreting our results, one
might consider the concept of comorbidity. We focused on
the symptoms of two key affective mental health disorders,
anxiety and depressive symptoms. However, our data do
not enable further confirmation of these patterns or factors
behind potentially varying patterns. Moreover, as we fo-
cused on symptoms, and not medical conditions, we pre-
ferred to refer to co-occurrence of the symptoms rather
than comorbidity. Although high levels of the included
symptoms can be “morbid”, the results of this study are
highlighted from the public health and societal perspective,
particularly emphasizing the joint trajectories of the
included symptoms. Their potential consequences could be
assumed to be related to the stability of work careers, for
example [31, 32].
The results further showed that while depressive and
anxiety symptoms co-occurred, depressive symptoms in-
creased for the groups with late sharply increasing and
very high and increasing level of symptoms, but tended
to slightly decrease for the other groups from adoles-
cence to adulthood. In turn, anxiety symptoms tended
to be either stable low or very low, or increase first and
decrease or be stable later, or increase only after the age
of 30 years. The rationale for focusing on depressive and
anxiety symptoms together was to confirm whether the
increase in anxiety could be observed in both symptoms.
In all, the results suggest that when being on a trajectory
of high levels of depressive symptoms or increasing de-
pressive symptoms, it is most likely that the person is
also on a high-level or high and increasing trajectories of
anxiety and somatic symptoms. This means that symp-
toms do not typically change from depressive symptoms
to anxiety or the other way round, but the co-occurrence
of these symptoms appears to be a long-term situation
over the lifespan. Such an interpretation is also line with
the evidence that mental health problems begin early in
life and high levels of symptoms are persistent from
childhood to adulthood [31–33].
As early-onset mental disorders are a key cause of
work disability [34, 35], an implication of this study is
that interventions for their prevention and treatment
should be targeted as early as possible. This is based on
our findings regarding the high stability of the symp-
toms, and high and increasing level of co-occurring
symptoms already from adolescence. Thus, any interven-
tions in later midlife are likely to be less effective. In
another words, as the co-occurrence of the high level of
symptoms has its roots in adolescence, preventive
measures need to be targeted as early as possible, before
the symptoms develop. Given that the burden of mental
disorders is even projected to grow in the future, this
further highlights the need for early detection of the risk
factors of mental ill-health before young people become
economically inactive [36–38].
Methodological considerations
A limitation of this study is the relatively small sample size,
which did not allow for a more detailed sub-group analysis.
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It needs to be further acknowledged that we examined
symptoms instead of clinical depression, anxiety disorder,
or somatic diseases. However, similar symptoms are typic-
ally collected in surveys. The validation of the variables
used has been published earlier in more detail, and the
measures have been found to have acceptable face validity
[27, 28]. Thus, although the self-reported symptoms are
not to be used for any diagnosis, most of the same ques-
tions are included e.g. in DSM V diagnostic criteria for de-
pression and anxiety [39]. Somatic symptoms have, in turn,
been found to predict severe mental disorders [40], al-
though we acknowledge that the measure is complex and
under debate [41]. Furthermore, we cannot exclude that
some of the symptoms were due to severe diseases, such as
lung disease development, for example. However, as the
participants were adolescents at baseline, and relatively
young at the end of the follow-up as well, severe somatic
causes are less likely than e.g. in elderly populations as a
cause of the symptoms. Nonetheless, we preferred to use
the term somatic symptoms in place of functional somatic
symptoms for better accuracy. Moreover, we acknowledge
that our somatic symptoms do not make an actual somatic
symptom disorder, which would necessitate inclusion of
some critical aspects such as excessive thoughts, feelings,
or behaviors related to the somatic symptoms [39]. As our
main interest was not specifically on the somatic symp-
toms or somatic symptoms disorder, but on the joint oc-
currence of somatic and mental symptoms, missing some
items is less crucial. Although we used key symptoms of
somatic symptoms, as judged by experts and following pre-
vious procedures [28], some of the symptoms further are
more common than others. Thus, the score does not
distinguish between the symptoms, which could partly
account for the results. However, the sample size did not
allow for more detailed groupings of the symptoms, nor
for their severity. One might further have high levels of
some somatic symptoms and low levels of mental symp-
toms, but co-occurrence still appears strong. Thus, during
the follow-up of 27 years, participants showed either low/
medium or high/increasing levels in all the symptoms, and
the analytical method did not find groups constituting
exceptions to the co-occurrence shown. Instead, the levels
remained stable throughout the follow-up.
The strengths of our study were a long follow-up and
the opportunity to examine paths from adolescence to
midlife, and the joint trajectory modeling, providing
novel evidence about mental health trajectories and co-
occurrence of symptoms during the lifespan. Further-
more, both women and men were included, and showed
similar development over time despite known difference
in the prevalence of mental and somatic symptoms [5,
29]. Also in our additional analyses (data not shown),
women were more likely to belong to the high level tra-
jectories and men to low level trajectories. However,
joint development of symptoms was similar, and the
same trajectory groups were identified in the gender
stratified analyses, justifying our decision to show the re-
sults pooling women and men. Additionally, response
rates to the surveys remained exceptionally high
throughout the follow-up, with 94% of still living partici-
pants responding at the final survey [27]. Thus, the co-
hort remained representative of the target population,
and non-response and attrition are unlikely to account
for findings to any great extent, such as changes in men-
tal health. Among the small percentage of non-respon-
dents, boys were somewhat overrepresented, as well as
those with low grades from their compulsory education,
and boys and girls with low parental education. We ac-
knowledge that it remains possible that many contextual
factors influenced the response pattern, as is always the
case when collecting any data. While only one area in
Sweden was included, the cohort has been shown to be
representative of the same-age Swedish population in re-
lation to sociodemographic factors, health status, and
health behavior [27]. Finally, a particular strength of this
study was the use of a method, namely a Group Based
Trajectory Analysis (GBTA) that can be seen as a novel
contribution to this area. More specifically, with the
GBTA we were able to produce novel evidence about
the development of the co-occurrence of depressive,
anxiety and somatic symptoms from adolescence to mid-
life. Advantages of GBTA are the ability to identify quali-
tatively distinct developmental curves that are not
directly observable from the series of repeated measure-
ments of mean development. Thus, GTBA represented
an alternative to the more traditional longitudinal ana-
lyses, where the analysis is most often based on the as-
sumption of a single homogenous population. Thus,
groups were obtained from the data, without any prior
assumptions about the groups. With the method, results
can be obtained and visualized either in an easily under-
standable format or in a broader statistical detail. More-
over, when the method is compared to e.g. latent growth
mixture modeling, GBTA provides a more parsimonious
multivariate model due to simple variance-covariance
structure. In the more flexible latent growth mixture
model with different covariance parameters for all the
variables the number of estimated parameters easily
grows too large for practical multivariate implementa-
tions. Thus, GBTA provides the opportunity to identify
groups of people in the data that have similar develop-
ment in their symptoms over time. In other words, this
a more person-oriented approach, where we do not
make strong assumptions beforehand, or classify people
based on any predefined cut points to specific groups.
Instead, the GBTA allowed us to identify what kind of
actual latent groups there are in the data. It should be
noted though that as GBTA is based on mixture models
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and groups are only approximations, careful interpret-
ation of the results is important, and using them
accordingly.
In conclusion, the results of this study suggest that co-
occurrence of high and increasing levels of depressive,
anxiety and somatic symptoms can be seen in the joint
trajectories across the lifespan, from adolescence to mid-
life. These findings should be considered in clinical prac-
tice to detect mental health problems in their early
phase, and paying special attention to the potential co-
occurring symptoms. In addition to better maintenance
of mental health, this is likely to have further significant
societal impacts, e.g. in the prevention of work disability
and other adverse employment outcomes, supporting
current efforts to extend work careers also from their
beginning and in early midlife.
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